Concepedia

Publication | Open Access

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma

38

Citations

20

References

2021

Year

Abstract

ClinicalTrials.gov Identifier: NCT01572480.

References

YearCitations

Page 1